Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.27
0.060.83%
Last update: Dec 15, 9:30 AM
Comments
Loading...
Myriad Genetics (MYGN) Stock Price, Quote, News & History
MYGNNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Myriad Genetics (MYGN) stock?
You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.
Who are Myriad Genetics (MYGN) competitors?
Other companies in Myriad Genetics’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), CytomX Therapeutics Inc (NASDAQ:CTMX), 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Prothena Corp PLC (NASDAQ:PRTA) and Cullinan Therapeutics Inc (NASDAQ:CGEM).
What is the forecast, or price target, for Myriad Genetics (MYGN) stock?
Myriad Genetics has a consensus price target of $14.50.
What is the current price for Myriad Genetics (MYGN)?
The stock price for Myriad Genetics (NASDAQ: MYGN) is $7.27 last updated December 15, 2025 at 9:30 AM EST.
Does Myriad Genetics (MYGN) pay a dividend?
There are no upcoming dividends for Myriad Genetics.
When is Myriad Genetics (NASDAQ:MYGN) reporting earnings?
Myriad Genetics does not have any upcoming earnings scheduled.
Is Myriad Genetics (MYGN) going to split?
There is no upcoming split for Myriad Genetics.
What sector and industry does Myriad Genetics (MYGN) operate in?
Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
